Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Screening|June 26, 2013
A label-free LC/MS/MS-based enzymatic activity assay for the detection of genuine caspase inhibitors and SAR developmentMichel C Maillard, Celia Dominguez, Mark J Gemkow, et al.
Journal of Biomolecular Screening|April 17, 2010
A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitorsSabine Schaertl, Michael Prime, John Wityak, et al.
Current Drug Discovery Technologies|February 14, 2006
Experiences in implementing uHTS--cutting edge technology meets the real worldPhilip Gribbon, Sabine Schaertl, Malcolm Wickenden, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's DiseaseJohn Wityak, Michael E Prime, Frederick A Brookfield, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's DiseaseMichael E Prime, Frederick A Brookfield, Stephen M Courtney, et al.
Science Translational Medicine|February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's diseaseDaniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2025
Orthosteric inhibition of MutSβ ATPase function: First disclosure of MSH3-bound small molecule inhibitorsGareth N Brace, Karsten Tillack, Peter D Johnson, et al.
Scientific Reports|September 10, 2021
Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidatesFrank Herrmann, Manuela Hessmann, Sabine Schaertl, et al.
Pageof 2